Jump to navigation
The latest clinical and political news for Australian Rheumatologists
It's a more common comorbidity than you think.
Study fails to back off-label use.
Diabetes and osteoarthritis; TNF inhibitors in kids; Ankylosing spondylitis.
There may be a narrow window of opportunity for complete remission.
First RA brain-imaging studies suggest it does
Information and empathy are important to patients
Affected patients with early systemic sclerosis need multi-disciplinary care, researchers say.
JIA in pregnancy | Bones and ankylosing spondylitis | Leflunomide and birth defects
Internet discussion site reveals poor grasp of aetiology and management strategies.
Snapshot from real-world data on treatment duration in rheumatoid arthritis.
It's not just about the ageing population, specialists say.
ACCC says legal case resembles $6 milllion action on Nurofen specific branding.
Most US advice is based on opinion or case reports.
Study shows cells in inflamed joints have low sensitivity to 1,25(OH)D3.
Multi-disciplinary care largely a pipe dream, study shows.
Methotrexate appears to at least delay RA onset.
A long-term patient needs hospital care. But was her management evidence-based?
Evidence is being ignored despite concern over harms and cost, researchers say.
Febuxostat linked to increased risk of cardiac and all-cause mortality.
Stepwise febuxostat | Assessing patient fears | Resistance exercise in RA
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.